Research programme: oral therapeutics - Bionex Pharmaceuticals
Latest Information Update: 16 Nov 2016
At a glance
- Originator Bionex Pharmaceuticals
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Mycoses; Pain
Most Recent Events
- 15 Nov 2016 Early research in Mycoses in USA (PO) before November 2016
- 15 Nov 2016 Early research in Pain in USA (PO) before November 2016